LEXARIA BIOSCIENCE CORP. Operating Lease, Payments
LEXARIA BIOSCIENCE CORP. (LEXX) reported Operating Lease, Payments of $26.88 thousand for the 9-month period ending 2024-05-31, per its 10-Q filed 2024-07-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-07-12
- LEXARIA BIOSCIENCE CORP. operating lease, payments for the quarter ending 2024-05-31 was $8.96K.
- LEXARIA BIOSCIENCE CORP. operating lease, payments for the quarter ending 2024-02-29 was $8.96K.
- LEXARIA BIOSCIENCE CORP. operating lease, payments for the quarter ending 2023-11-30 was $8.96K, a 80.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. operating lease, payments for the quarter ending 2022-11-30 was $44.81K.
- LEXARIA BIOSCIENCE CORP. operating lease, payments for fiscal 2021 was $43.95K, a 0.43% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. operating lease, payments for fiscal 2020 was $43.76K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2024-05-31 | $8.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12 | $17.92K derived: sum of 2 quarters · filed 2024-07-12 | $26.88K 10-Q · filed 2024-07-12 | ||
| 2024-02-29 | $8.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09 | $17.92K 10-Q · filed 2024-04-09 | |||
| 2023-11-30 | $8.96K 10-Q · filed 2024-01-12 | ||||
| 2023-08-31 | $44.81K 10-Q · filed 2024-07-12 | ||||
| 2022-11-30 | $44.81K 10-Q · filed 2024-01-12 | ||||
| 2021-08-31 | $32.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $43.95K 10-K · filed 2021-11-29 | |||
| 2021-05-31 | $10.99K 10-Q · filed 2021-07-15 | ||||
| 2020-11-30 | -$10.99K 10-Q · filed 2021-01-14 | ||||
| 2020-08-31 | $43.76K 10-K · filed 2021-11-29 | -$43.76K 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |